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mproving Exercise Tolerance
n Chronic Heart Failure
Tale of Inspiration?*
erome L. Fleg, MD, FACC, FAHA
ethesda, Maryland
yspnea and exercise intolerance are hallmarks of chronic
eart failure (HF). Over the past 3 decades, the importance
f aerobic exercise capacity as an index of functional status
nd a prognostic marker in chronic HF has become widely
ecognized. A landmark study by Weber et al. (1) published
n 1982 proposed a new classification system of chronic HF
everity, on the basis of measured peak oxygen consumption
V˙O2). Many subsequent studies have documented a strong
elationship between peak V˙O2 and mortality in chronic HF
atients. On the basis of the dismal survival in patients with
markedly reduced peak V˙O2, a peak V˙O2 14 ml/kg/min
ecame a major criterion for referral for possible heart
ransplantation (2). Despite the significant improvement in
ymptoms and survival observed with pharmacologic block-
de of the renin-angiotensin and beta adrenergic systems,
uch drug therapy generally has little impact on exercise
apacity (3,4). In contrast, aerobic training programs in-
rease peak V˙O2 by 15% to 25% in chronic HF patients,
imilar to the degree of improvement observed in normal
ndividuals after such training (5).
See page 1663
Because both the quality of life and longevity in chronic
F are so strongly influenced by aerobic capacity, it is
mportant to understand the factors that limit peak V˙O2 in
his disorder. Peak V˙O2 is determined by the product of
ardiac output (CO) (i.e., the central component) and
rteriovenous oxygen difference (AVO2 diff) (i.e., the pe-
ipheral component) during exhaustive aerobic exercise.
lthough both peak CO and AVO2 diff are reduced in
hronic HF, the dominant deficit is in peak CO (5,6). In
eber’s classification scheme, invasively determined peak
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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hose of the National Institutes of Health or the Department of Health and Human
ervices.O/m2 ranged from a mean of 7.8 l/min/m2 in Class B
atients (peak V˙O2 16 to 20/ml/kg/min) to 3.0 l/min/m
2 in
lass D (peak V˙O2 10/ml/kg/min) (1). A modest reduc-
ion in peak heart rate contributes to the reduced CO, but
he primary limitation to increasing CO during exercise is
he blunted ability of the failing heart to augment stroke
olume, due to reduced reserve of both preload and con-
ractility (5,6).
Recent years, however, have witnessed increasing recog-
ition of noncardiac limitations to exercise in chronic HF
atients. Numerous studies have documented a myopathy of
he skeletal muscle in this condition, characterized by
educed muscle mass and strength, with decreases in oxida-
ive type I fibers, mitochondrial volume density, and oxida-
ive enzyme activity (5,7,8). These myopathic changes along
ith impaired regulation of blood flow to exercising muscle
9) help to explain the blunted augmentation of AVO2 diff
ith aerobic exercise.
What role, if any, do the lungs play in the exercise
ntolerance of chronic HF? It is well known that ventilation
s excessive for the work performed in HF patients, probably
wing to a combination of increased physiological dead
pace and greater lactate production. The magnitude of this
entilatory excess during exercise, quantified by the venti-
ation/carbon dioxide production slope (V˙E/V˙CO2), is now
ecognized to correlate with clinical HF severity and to
redict outcomes, independent of peak V˙O2 (10,11). This
xaggerated ventilatory response, coupled with reduced lung
ompliance and possibly increased airway resistance, con-
ributes to the sensation of excessive respiratory effort during
xercise in patients with chronic HF.
An additional potential ventilatory limitation to exer-
ise in chronic HF is weakness of the respiratory muscles
hemselves, best quantified by reduced maximal inspiratory
ressure (PImax). In a study of 244 patients with systolic
F, mean PImax was reduced 28% compared with healthy
ontrol subjects and was a strong independent predictor of
-year mortality (12). Although the precise etiology of this
espiratory muscle dysfunction is unclear, diaphragm biop-
ies have demonstrated a variety of histological abnormali-
ies, including type I fiber atrophy similar to that observed in
imb skeletal muscle.
In a prior issue of the Journal, Dell’Ago et al. (13)
andomized 32 patients with chronic systolic HF and
nspiratory muscle weakness, defined by PImax 70% of
redicted, to 12 weeks of inspiratory muscle training (IMT)
0 min daily or to a placebo IMT with no inspiratory load.
he IMT group experienced a 115% increase in PImax,
7% increase in treadmill peak V˙O2, 19% increase in 6-min
alk, and 14% reduction in V˙E/V˙CO2 slope, whereas these
ariables were unchanged in the placebo IMT group. The
ncrease in peak V˙O2 correlated well with the change in
Imax (r  0.62). Quality of life scores on the Minnesota
iving With Heart Failure questionnaire also improved
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April 29, 2008:1672–4 Editorial Commentfter IMT, and this effect was partially maintained at 1-year
ollow-up.
In the current issue of the Journal, investigators from this
ame laboratory examine the changes induced by a 4-week
MT program (of identical intensity and session frequency
s in their previous study) on resting and exercise limb blood
ow in a new group of 18 chronic HF patients with
nspiratory muscle weakness as defined in the preceding text
14). Before IMT, the HF patients experienced greater
eduction in resting calf blood flow and a blunted rise in
orearm blood flow response to rhythmic handgrip exercise
uring inspiratory muscle loading compared with 10 healthy
ontrol subjects. After only 4 weeks of IMT, HF patients
emonstrated hypertrophy of the diaphragm and improved
esting and exercise limb blood flow during inspiratory
uscle loading as well as longer time to fatigue during
andgrip exercise (14).
The finding of enhanced limb blood flow after IMT in
his study provides a potential mechanism for an increase in
erobic performance after IMT in chronic HF patients.
rior studies in normal individuals by Dempsey et al.
15,16) have shown that the work of breathing incurred
uring maximal aerobic exercise causes vasoconstriction in
eg muscles, compromising leg blood flow. This response,
abeled the inspiratory muscle metaboreflex, seems to be
ediated by the activation of type IV phrenic afferent fibers
y accumulated metabolites, causing an increase in sympa-
hetic outflow (17). The current study demonstrates that
his reflex is exaggerated in chronic HF patients, further
ompromising limb blood flow, but that this adverse re-
ponse is markedly attenuated by IMT (14). Limitations to
he current study, appropriately acknowledged by the inves-
igators, include the lack of a placebo IMT group, the
9-year greater mean age of the HF patients relative to
ontrol subjects, and the known hemodynamic differences
etween handgrip and aerobic exercise. Nevertheless, these
esearchers should be congratulated on extending their prior
ndings on the salutary effects of IMT in chronic HF
atients.
The provocative findings of these 2 studies regarding the
enefits of IMT in chronic HF (13,14) must be tempered by
hose of other investigators. Two prior randomized con-
rolled trials of IMT failed to elicit improvement in exercise
apacity or dyspnea in similar patient samples (18,19). In
nother study, the acute addition of respiratory dead space
oading during cardiopulmonary exercise testing in patients
ith chronic HF did not reduce their peak V˙O2, because the
ncreased ventilatory requirement was met from their re-
erve capacity (20). Finally, acutely unloading the work of
reathing by substituting helium for nitrogen in the inhaled
as mixture failed to increase peak treadmill V˙O2, although
xercise duration was lengthened (21). These negative studies
re consistent with the diagnostic algorithm that separates
ardiac from pulmonary causes of exertional dyspnea on the
asis of a reduced ventilatory reserve capacity during peak
xercise in pulmonary but not cardiac patients (22).Given the conflicting findings in the published reports
egarding the role of the lungs in limiting aerobic capacity in
atients with chronic HF, what role should IMT have in
his population? Clearly, a major issue requiring resolution
s the proportion of chronic HF patients in whom inspira-
ory muscle weakness imposes a significant limitation to
erobic exercise. Although the experience of the Brazilian
nvestigators featured in the current issue of the Journal
uggests that approximately 30% of chronic HF patients
ave PImax 70% of predicted (14), the percentage of
atients meeting this criterion likely varies substantially
mong centers. Of note, a small study by Hughes et al. (23)
oncluded that mild reduction of diaphragmatic strength
ccurs in chronic HF but overall respiratory muscle strength
emains well preserved.
Several additional questions remain concerning the role
f IMT in chronic HF. Can patients who are likely to
enefit from IMT be identified clinically or should inspira-
ory muscle strength be determined in all HF patients?
hat are the optimal session frequency, intensity, and
uration and the optimal program length for IMT? Are the
enefits of IMT on exercise capacity and quality of life
dditive to those of conventional aerobic training programs?
erhaps most important, does IMT reduce the high mor-
idity and mortality of chronic HF? Indeed, the role of
erobic training remains unclear in this regard, although this
mbiguity should be resolved with the completion of the
ulticenter National Institutes of Health (NIH)-sponsored
F-ACTION (Heart Failure and A Controlled Trial
nvestigating Outcomes of Exercise TraiNing) trial within
he next few months (24).
eprint requests and correspondence: Dr. Jerome L. Fleg,
ivision of Cardiovascular Diseases, National Heart, Lung, and
lood Institute, 6701 Rockledge Drive, Room 8150, Bethesda,
aryland 20892. E-mail: flegj@nhlbi.nih.gov.
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